Bronfman E.L. Rothschild L.P. Buys 992 Shares of Amgen, Inc.


Bronfman E.L. Rothschild L.P. lifted its stake in Amgen, Inc. by 16.3% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 7,081 shares of the medical research company's stock after purchasing an additional 992 shares during the quarter.



from Biotech News